Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Pain 3Peripheral Nervous System Diseases 1Neurotoxicity Syndromes 1Neoplasms 1Multiple Myeloma 1Mucositis 1Lymphoma 1Intraoperative Complications 1Head and Neck Neoplasms 1Chronic Pain 1Cancer Pain 1Abnormalities, Radiation-Induced 1

Interventions

Morphine 15Oxycodone 13Fentanyl 9nabiximols 5Methadone 5Lidocaine 5Acetaminophen 5resiniferatoxin 4Ethanol 4Acupuncture Therapy 4Transcutaneous Electric Nerve Stimulation 3Hydromorphone 3Transcranial Direct Current Stimulation 2Surveys and Questionnaires 2Standard of Care 2Sodium Bicarbonate 2Radiofrequency Ablation 2Pharmaceutical Services 2Naloxone 2Ketamine 2Electroacupuncture 2Dronabinol 2Control Groups 2Buprenorphine 2Analgesics, Opioid 26'-fluoro-4',9'-dihydro-N,N-dimethyl-4-phenylspiro(cyclohexane-1,1'(3'H)-pyrano(3,4-b)indol)-4-amine 2tanezumab 1rofecoxib 1naloxegol 1incobotulinumtoxinA 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Cancer Pain × Pain Management × Clear all
NCT05877521 2025-09-23

Mindfulness-oriented Recovery Enhancement (MORE) for Cancer Pain Relief

Memorial Sloan Kettering Cancer Center

Phase 2 Active not recruiting
76 enrolled

Cancer Pain, Chronic Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡